Davis's Drug Guide
bendamustine
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
ben-da-muss-teen
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Belrapzo
- Bendeka
- Treanda
- Vivimusta
Ther. Class.
Pharm. Class.
benzimidazoles
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Bendamustine." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/109374/all/bendamustine.
Vallerand AHA, Sanoski CAC, Quiring CC. Bendamustine. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109374/all/bendamustine. Accessed September 29, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Bendamustine. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109374/all/bendamustine
Vallerand AHA, Sanoski CAC, Quiring CC. Bendamustine [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 September 29]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109374/all/bendamustine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - bendamustine
ID - 109374
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109374/all/bendamustine
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -